CN
62-75-9
Applied Filters:
Keyword:'62-75-9'
Showing 1-30 of 260 results for "62-75-9" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7 2 18 22 5 75 68 84 54 20 94 97 73 75
15 6 62 116 102 101 94 60
The Effective Use of Protein Kinase Inhibitors
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7 2 18 22 5 75 68 84 54 20 94 97 73 75
15 6 62 116 102 101 94 60
Anti-BACE 1 N-Terminus (46-62) antibody produced in rabbit (B0681)
broad
band at 60-75 kDa). Applications include immunoblotting.
Staining of BACE-1 in immunoblotting is specifically
inhibited with BACE-1 immunizing peptide (human,
amino acids 46-62, with C-terminally
Data Sheet - SAB4200694
optimal working concentration by titration
test.
References
1. Otey C., et al., Hybridoma, 9, 57-62 (1990).
2. Sancéau J., et al., J Biol Chem., 278, 36537-46
(2003).
Impurities & Related Compounds: Reference Materials
2387-23-7
79794-75-5
133284-74-9
170727-59-0
125743-80-8
29976-53-2
100643-71-8
38092-89-6
31251-41-9
75330-75-5
73573-88-3
109273-98-5
149756-62-7
77517-29-4
Series 8000 Stirred Cells and Ultrafiltration Membranes
Diameter: 25 mm 25 mm 43 mm 62 mm 76 mm
Effective Membrane Area: 0.9 cm 4.1 cm 13.4 cm 28.7 cm 41.8 cm
Hold-up Volume:* 0.07 mL 0.2 mL 0.5 mL 1.2 mL 1.5 mL
Maximum Operating Pressure: 75 psi (5.3 kg/cm2)
Relief
MMP Activation Chart
6691
APMA, 1mM +
activeMMP-7 (1:1)
37oC, 12h 83 62 66.6* M
75RTPR & F88QTFE; C-
term cleavage
0.7x Imai, jbc270/1995/6691
MMP-9
92kDa
Gelatinase,
Gelatinase B
92Gly
Data Sheet - R1148
Reserved.
Page 2 of 2
References:
1. Rogosa, M., et al., (1951). J. Bact. 62. 1,132.
2. MacFaddin, J.F., (1985). Media for Isolation-Cultivation-Identification-Maintenance of
Product Information Sheet - K0250
al., Kainic acid induces
apoptosis in neurons. Neuroscience, 75, 1047-1055
(1996).
N
H
CO2H
CO2HCH3
CH2
· H2O
9. Routbort, M.J., et al., Seizures, cell death, and
mossy fiber
HUMAN INSULIN SPECIFIC RIA KIT
17 17 100
75 µl 15 88
50 µl 15 88
25 µl 15 88
2 100 µl 42
Data Sheet - SAB4200813
2016).
2. Tian, Z. et al., PLoS One., 9, e100715 (2014).
3. Wang, L. et al., Cell Signal., 27, 908-22 (2015).
4. Scholl, E.S. et al., Channels (Austin), 8, 62-75
(2014).
5. Gonzalez, J.P. et al.
MultiScreen HTS Glass Fiber Filter Plates
Quality Results
Sc
op
ol
am
in
e
Bo
un
d
(%
o
f C
on
tro
l)
100
75
50
25
0
–9 –8 –7
Pirenzipine (Log M)
–6
Triplicate Data
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
. Cell. Biol., 21, 2393-2403 (2001).
61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000).
62. Qi, M., et al., J. Biol. Chem., 276, 15868-15875 (2001).
63. Maeda, N., et al., J. Biol. Chem., 274
Product Information Sheet - G2536
Storage Temperature 2-8 °C
CAS RN: 82410-32-0
Synonyms: 9-(1,3-Dihydroxy-2-propoxymethyl)guanine;
2′-Nor-2′-deoxyguanosine; 2′-NDG; BIOLF-62; DHPG;
BW-759U
Product Description
Molecular formula
Anti-CRMP1 (C2868)
on agarose.
Anti-CRMP1 specifically recognizes human, rat, and
mouse CRMP1 by immunoblotting, ~62 kDa. Staining of
the CRMP1 band in immunoblotting is specifically
inhibited by the immunizing peptide
Data Sheet - A1983 - Lot 031M0757
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 031M0757:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 031M0757:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 041M0992
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 041M0992:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 041M0992:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 061M0745
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 061M0745:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 061M0745:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 019K1606
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 019K1606:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 019K1606:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 039K0624
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 039K0624:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 039K0624:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 020M0849
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 020M0849:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 020M0849:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 050M0844
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 050M0844:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 050M0844:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Data Sheet - A1983 - Lot 020M0846
cycles.
Figure 1.
SDS-PAGE Gel of Lot Number 020M0846:
>75% (densitometry)
Figure 2.
Specific Activity of Lot Number 020M0846:
62 nmole/min/mg
Procedure
Preparation Instructions
Kinase Assay
Anti-CRMP-1 (N-terminal) (C4118)
Anti-CRMP1 (N-terminal) specifically recognizes human,
rat, and mouse CRMP1 by immunoblotting, ~62 kDa.
Staining of the CRMP1 band in immunoblotting is
specifically inhibited by the immunizing peptide
Product Information Sheet - A6814
of -amylases from
different strains of Bacillus licheniformis have been
published:
NCIB 6346:2 62 kDa
44MB82-A:5 58 kDa
MTCC 1483:6 58 kDa
Crystal structures for -amylase from B. licheniformis
Anti-CRMP2 (C2993)
agarose.
Anti-CRMP2 specifically recognizes human, rat, and
mouse CRMP2 by immunoblotting (62 kDa). Staining
of the CRMP2 band in immunoblotting is specifically
inhibited by the immunizing peptide
App Note: Cannabinoids Analysis in Cannabis using a High Resolution Monolithic Silica HPLC
standard
CBG
bud
standard
Nom
175
150
120
100
75
50
25
0
220 240 260 280 300 320 340 360 380 nm
∆9-THC
bud
standard
Nom
250
200
150
Monoclonal Anti-Talin-Biotin antibody produced in mouse (B6059)
determine their optimum working
dilutions by titration.
References
1. Otey, C., et al., Hybridoma, 9, 57-62 (1990).
2. Burridge, K., and Connell, L., Cell Motil., 3, 405-417
(1983).
3. Beckerle, M.
Data Sheet - P9372
, et al., Br. J. Pharmacol., 141,
Suppl 1:S1-S126 (2004).
2. MacKinnon, R., FEBS Letters, 555, 62-65 (2003).
3. Gutman, G.A., et al., Pharmacol. Rev., 55, 583-586
(2003).
4. Knaus, H.G. et
Data Sheet - L0415
Trends Genet., 10,
286-292 (1994).
7. Gyuris, J., et al., Cell, 75, 791-803 (1993).
8. Ruden, D.M., et al., Nature, 350, 250-252 (1991).
9. Yang, X., et al., Cell, 89, 1067-1076 (1997).
10. Jahn, T., et
Page 1 of 9